Response To Serotonin and Its Antagonists in Patients With Rheumatoid Arthritis and Related Diseases*†

Abstract

Get full access to this article

View all access options for this article.

References

Wooley, D.W. , AND Shaw, E. : Some neurophysiological aspects of serotonin . Brit. M. J., 2: 122, 1954.

Scherbel, A.L. : The effect of Marsilid in patients having rheumatoid arthritis; the theoretical causal role of certain amine oxidases . J. Clin. & Exper. Psychopath., 19: 118,1958.

Sollero, L. , Page, I.H. , AND Salmoiraghi, G.C. : Brom-Iysergic acid diethylamide; highly potent serotonin antagonist. J. Pharmacol. & Exper. Therap., 117: 10, 1956.

Gerletti, A. , AND Doepfner, W. : Comparative study on serotonin antagonism of amide derivatives of lysergic acid and of ergot alkaloids. J. Pharmacol. & Exper. Therap., 122: 124, 1958 .

Gaddum, J.H. , Hameed, K.A. , Hathway , D.E. , AND Stephens , F.F. : Quantitative studies of antagonists for 5-hydroxytryptamine. Quart. J. Exper. Physiol., 40: 49, 1955.

Reid, G. : Circulatory effects of 5-hydroxytryptamine. J. Physiol. , 118: 435, 1952.

Schneckloth, R.D. , Page, I.H. , Del Greco, F. , AND Corcoran, A.C. : Effect of serotonin antagonists in normal subjects and patients with carcinoid tumors . Circulation, 16: 523, 1957.

Glover, W.E. , Marshall, R.J. , AND Whelan, R.E. : Antagonism of vascular effects of 5-hydroxytryptamine by BOL 148 and sodium salixylate in human subject. Brit. J. Pharmacol., 12: 498, 1957.